Food Allergy Market Size, Share, Growth, and Industry Analysis, By Type (Blood Test, Skin Test), By Application (For Baby Food, For Bakery & Confectionary Products, For Dairy Products, For Fish and Sea Food, Others), and by Regional Insights and Forecast to 2031

Updated On: 06 May 2024

FOOD ALLERGY MARKET REPORT OVERVIEW

• 

• to learn more about this report

The global food allergy market size was USD 6 million in 2020 and the market is projected to touch USD 7 million by 2027, exhibiting a CAGR of 3.7% during the forecast period.

The food allergy market is a dynamic sector witnessing significant growth as awareness and diagnosis of food allergies increase globally. With a rising prevalence of allergies to common foods such as nuts, dairy, and gluten, there is a heightened demand for innovative diagnostic tools, treatment options, and allergen-free products. Pharmaceutical companies are investing in research and development to create effective and targeted allergy therapies. Additionally, the food industry is adapting by offering a diverse range of allergy-friendly products. As governments and healthcare organizations focus on addressing the challenges posed by food allergies, the market is poised for expansion, driven by advancements in technology and a growing emphasis on improved patient outcomes.

COVID-19 Impact: Market Growth Restrained by Pandemic Due to Supply Chain Disruptions

The global COVID-19 pandemic has been unprecedented and staggering, with the market experiencing lower-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden market growth reflected by the rise in CAGR is attributable to market’s growth and demand returning to pre-pandemic levels.

The COVID-19 pandemic has had a dual impact on the food allergy market. On one hand, it has intensified concerns and precautions related to health, leading to increased awareness of food allergies. However, the economic repercussions and disruptions in the supply chain have posed challenges. The financial strain on consumers may limit their ability to invest in specialized allergen-free products, impacting food allergy market growth. Moreover, the focus on pandemic-related research and healthcare resources may divert attention from food allergy innovations. Despite these hurdles, the heightened awareness of health and wellness may drive a long-term positive impact on the food allergy market, as individuals seek safer and healthier food options.

LATEST TRENDS

"Revolutionizing Allergen Safety with Blockchain in the Market Helps Market Grow"

A burgeoning trend in the food allergy market is the adoption of blockchain technology to enhance allergen safety. Blockchain's decentralized and secure ledger system transforms the way allergen information is tracked and communicated throughout the food supply chain. This technology ensures transparency and traceability, allowing real-time tracking of food ingredients from production to consumption. The immutable nature of blockchain guarantees accurate and up-to-date allergen information, minimizing the risk of contamination. Additionally, in the event of a food recall or allergen-related issue, blockchain facilitates rapid and verifiable communication, ensuring a swift response to protect individuals with food allergies.

FOOD ALLERGY MARKET SEGMENTATION

• 

• to learn more about this report

• By Type

Based on type the global market can be categorized into blood test, skin test

Blood Test: Blood tests for food allergies involve analyzing specific antibodies to identify allergic reactions, offering a comprehensive and accurate assessment of immune responses to various allergens.

Skin Test: Skin tests entail applying allergens to the skin surface and observing for reactions, providing a quick and cost-effective method to identify potential allergens and assess sensitivity levels.

• By Application

Based on application the global market can be categorized into for baby food, for bakery & confectionary products, for dairy products, for fish and sea food, others

For Baby Food : Products specifically designed and produced for infants and young children.

For Bakery & Confectionery Products: Items intended for use in baking and the production of confectionery goods, such as cakes, cookies, and sweets.

For Dairy Products: Solutions tailored for use in the dairy industry, including milk, cheese, yogurt, and other dairy-based products.

For Fish and Seafood: Specialized applications related to the processing and preservation of fish and seafood products.

Others: This category may encompass a range of applications not explicitly mentioned above, possibly including products for meat, beverages, or other food segments not covered by the specified categories.

DRIVING FACTORS

"Increasing Prevalence and Awareness of Food Allergies to Drive the Market"

The food allergy market is driven by the escalating prevalence of food allergies worldwide. As more individuals are diagnosed with allergies to common foods such as nuts, dairy, and gluten, there is a growing demand for innovative diagnostic tools, treatments, and allergen-free products. Simultaneously, heightened awareness about food allergies, driven by educational initiatives and increased media coverage, encourages early diagnosis and proactive management.

"Advancements in Diagnostic Technologies and Treatment Options to Boost the Market"

The continuous evolution of diagnostic technologies and treatment options serves as another key driving force in the food allergy market. Innovations in diagnostic tools, including molecular and genetic testing, enable more accurate and timely identification of food allergies. Additionally, ongoing research and development efforts result in the introduction of advanced treatment options, ranging from immunotherapies to personalized medicine, improving overall outcomes for individuals with food allergies.

RESTRAINING FACTORS

"Economic Constraints to Negatively Impact the Market Growth"

A restraining factor in the food allergy market is the economic burden faced by individuals with food allergies. The cost associated with allergen-free products, specialized treatments, and diagnostic procedures can be substantial. Economic constraints may limit accessibility to these essential resources, hindering optimal management of food allergies. This financial barrier poses a challenge for both individuals seeking appropriate care and the broader market, impacting the growth potential of allergen-free product segments. Addressing affordability issues and exploring avenues for cost-effective solutions are crucial steps to mitigate this restraining factor in the food allergy market.

FOOD ALLERGY MARKET REGIONAL INSIGHTS

• 

• to learn more about this report

"North America Emerges as the Pivotal Driver in the Market Due to Rapid Urbanization"

The market is primarily segregated into Europe, Latin America, Asia Pacific, North America, and Middle East & Africa.

North America takes the lead in the food allergy market share, emerging as a dominant region. The United States and Canada, with their advanced healthcare infrastructure and heightened awareness, play pivotal roles. A surge in research and development activities, coupled with a robust regulatory framework, positions North America at the forefront of food allergy management. The prevalence of food allergies, coupled with a strong emphasis on innovation and healthcare, contributes to the region's prominence in developing and adopting cutting-edge solutions for diagnosis, treatment, and prevention.

KEY INDUSTRY PLAYERS

"Key Industry Players Shaping the Market Through Innovation and Market Expansion"

Key industry players driving innovation and market expansion in the food allergy sector include Mylan N.V., now part of Viatris Inc., known for its focus on epinephrine auto-injectors. Sanofi S.A. contributes with a diverse portfolio of allergy treatments, emphasizing immunotherapies. DBV Technologies pioneers with Viaskin Peanut, an epicutaneous immunotherapy patch for peanut allergies. Aimmune Therapeutics, now under Nestlé Health Science, developed Palforzia, an oral immunotherapy for peanut allergies. Stallergenes Greer specializes in allergy immunotherapy, offering personalized solutions. Together, these companies shape the food allergy market by advancing treatments, improving accessibility, and raising awareness of allergic conditions.

List of Market Players Profile

• Alletess Medical Laboratory (U.S.)
• ALS Limited (Australia)
• Asurequality Ltd (New Zealand)
• Charm Sciences (U.S.)
• Crystal Chem, Inc (U.S.)
• Danaher Corporation (U.S.)
• Intertek Group (U.K.)
• Merieux Nutrisciences Corporation (U.S.)
• Microbac Laboratories (U.S.)
• Neogen Corporation (U.S.)

INDUSTRIAL DEVELOPMENT

October 2021: An industrial development in the food allergy market is the increasing focus on biotechnology to develop innovative treatments. Biopharmaceutical companies are leveraging biotechnological advancements to create targeted therapies for food allergies. These include oral immunotherapies and biologics designed to desensitize individuals to specific allergens. This shift towards biotechnology signifies a more precise and personalized approach to allergy management, offering hope for improved outcomes and quality of life for those affected by food allergies.

REPORT COVERAGE

The food allergy market is undergoing dynamic changes marked by significant advancements in biotechnology and a focus on personalized treatments. The integration of innovative therapies, such as oral immunotherapies and biologics, reflects a transformative shift in addressing food allergies. With North America playing a pivotal role due to heightened awareness and robust research activities, the global landscape is evolving to offer more targeted and effective solutions. As key industry players drive innovation and market expansion, there is a growing optimism for improved management and outcomes in the realm of food allergies. The ongoing developments underscore a commitment to enhancing the lives of individuals affected by these conditions through cutting-edge approaches.